[{"id":"2bca17a4-1b77-4b70-bb2a-a5dcd7c531ff","acronym":"","url":"https://clinicaltrials.gov/study/NCT05672147","created_at":"2023-01-05T14:58:28.476Z","updated_at":"2025-02-25T16:39:33.579Z","phase":"Phase 1","brief_title":"CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT05672147","lead_sponsor":"City of Hope Medical Center","biomarkers":" CD33","pipe":" | ","alterations":" CD33 positive","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anti-CD33 CAR T"],"overall_status":"Recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 12/07/2023","start_date":" 12/07/2023","primary_txt":" Primary completion: 09/03/2028","primary_completion_date":" 09/03/2028","study_txt":" Completion: 09/03/2028","study_completion_date":" 09/03/2028","last_update_posted":"2025-02-06"}]